Money

Novo Nordisk inventory surges 7% after Ozempic maker’s newest weight-loss drug exhibits promise

Pulse Reporter
Pulse Reporter
Novo Nordisk inventory surges 7% after Ozempic maker’s newest weight-loss drug exhibits promise




The brand new remedy targets intestine hormone GLP-1 but additionally mimics amylin, a hormone launched by the pancreas that suppresses starvation. Learn Extra

You Might Also Like

Ousted Paramount CEO Bob Bakish obtained a golden parachute price $69.3 million

Microsoft’s chief range officer research smaller corporations

Hermès leapfrogs LVMH to turn out to be Europe’s most useful luxurious firm after the Louis Vuitton proprietor reported downbeat outcomes

Dr. Oz says probiotic dietary supplements have wide-ranging well being advantages. Right here’s what science says

RFK Jr. blames these 5 environmental toxins for a spike in autism instances

Share This Article
Previous Article DeepSeek R1’s daring wager on reinforcement studying: The way it outpaced OpenAI at 3% of the fee DeepSeek R1’s daring wager on reinforcement studying: The way it outpaced OpenAI at 3% of the fee
Next Article IHG Rewards Traveler Credit score Card assessment: Full particulars IHG Rewards Traveler Credit score Card assessment: Full particulars
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More News